UK markets closed

BerGenBio ASA (BGBIO.OL)

Oslo - Oslo Delayed price. Currency in NOK
Add to watchlist
0.1424-0.0024 (-1.66%)
At close: 04:25PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
389
389
774
601
Operating expenses
Research development
129,136
202,403
205,820
185,234
Selling general and administrative
-
-
12,744
21,792
Total operating expenses
225,066
306,024
315,236
261,693
Operating income or loss
-224,677
-305,635
-314,462
-261,092
Interest expense
1,514
321
53
32
Income before tax
-225,954
-302,122
-309,364
-257,029
Income tax expense
0
0
0
0
Income from continuing operations
-225,954
-302,122
-309,364
-257,029
Net income
-225,954
-302,122
-309,364
-257,029
Net income available to common shareholders
-225,954
-302,122
-309,364
-257,029
Basic EPS
-0.55
-2.94
-3.04
-2.96
Diluted EPS
-0.55
-2.94
-3.04
-2.96
Basic average shares
804,599
102,663
101,876
86,776
Diluted average shares
804,599
102,663
101,876
86,776